Alkem Laboratories Ltd

Alkem Lab | 539523

Market Closed

₹5,723.00

+₹0.00 (+0.01%)

As on 19/11/25, 2:59 AM

Market Cap68,421.07 CR

Current Price₹5,723

High / Low₹5,868 / 4,491.65

PE Ratio26.94

Book Value₹1,002.5

Dividend Yield0.92%

ROCE20.03%

ROE19.94%

Face Value₹2.00

Current Vol.1,76,721

Average Vol.12,76,53,456

ISININE540L01014

PB Ratio4.87

Debt to Equity0.13

Net Profit Margin17.09

Operating Margin23.19

Stock cgart

Stock Performance

₹2,480₹2,490

₹2,500

Previous CloseToday's Open

₹1,800₹3,000

₹2,500

52W Low52W High

₹2,480Today's Open

₹2,490Previous Close

12,00,000Volume

₹1,80052W Low

₹3,00052W High

Ratios

No data available

About Company

Headquartered in Mumbai, India, Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations
The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products
The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and international markets
Alkem Laboratories Limited was incorporated as a private limited company on August 8, 1973 in Patna and subsequently became a deemed public limited company on October 26, 1988
Pursuant to Company passing a resolution under section 21 of Companies Act, 1956 and upon issuance of a fresh certificate of incorporation consequent on change of name dated August 21, 2001, the name of the Company was changed to 'Alkem Laboratories Limited' with effect from October 26, 1988
In 1978, the company established its first plant at Taloja Maharashtra
In 1992, the company established its manufacturing facility in Mandwa, Maharashtra, which was later converted into an API facility in 2005
In 2003, the company set up a research and development facility for ANDA development at Taloja, Maharashtra
During the year 2006, the company's anti-infective drug Taxim became the first anti-infective drug in the Indian pharmaceutical industry to cross Rs 100 crore in terms of domestic sales in India
In 2007, the company filed its first ANDA in the US for the drug Amlodipine

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

;

Technical Indicators

RSI64.57

SMA 205607.90

SMA 505518.07

SMA 1005280.03

SMA 2005108.05

SMA 105691.90

MACD_12_26_Days68.11

EMA10Day5682.72

EMA20Day5627.82

EMA50Day5508.94

MACD_12_26_9_Days10.54

EMA100Day5375.74

EMA200Day5275.46

Pivot Points

Volume Analysis

Growth Rate

Revenue Growth2.34%

ROE19.88%

EBITDA Margin23.19%

All figures in ₹ Crores

Indicators	2025	2024	2023	2022	2021
Revenue	12,964.52	12,667.58	11,599.26	10,634.19	8,865.01
Interest	121.70	112.41	107.36	52.37	58.92
Expenses	10,452.37	10,422.09	9,989.81	8,581.27	6,922.62
Financing Profit	3,005.89	2,556.33	1,825.53	2,215.57	2,175.60
Financing Margin %	23%	20%	16%	21%	25%
Other Income	493.74	310.84	216.08	162.65	233.21
Depreciation	357.16	299.30	310.42	303.96	274.58
Profit before tax	2,527.03	2,023.13	1,304.77	1,844.28	1,842.10
Tax %	12%	10%	23%	9%	12%
Net Profit	2,216.00	1,811.46	1,006.81	1,680.32	1,617.77
EPS in Rs	181.11	150.19	82.31	137.63	132.57

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

Deal	Date	Type	Quantity	Price	Traded %
ICICI PRUDENTIAL LIFE INSURANCE COMPANY LTD	22 Aug ‘24	Purchase	1,97,000	₹5,732.15	57.45%
KOTAK MAHINDRA MUTUAL FUND	22 Aug ‘24	Purchase	61,000	₹5,732.15	17.79%
COPTHALL MAURITIUS INVESTMENT LIMITED-NON ODI ACCOUNT	22 Aug ‘24	Purchase	17,500	₹5,732.15	5.10%
CITIGROUP GLOBAL MARKETS MAURITIUS PRIVATE LTD	22 Aug ‘24	Purchase	35,000	₹5,732.15	10.21%
CITIGROUP GLOBAL MARKETS MAURITIUS PRIVATE LIMITED-ODI	22 Aug ‘24	Purchase	75,000	₹5,732.15	21.87%
BNP PARIBAS ARBITRAGE -NON ODI	22 Aug ‘24	Purchase	35,000	₹5,732.15	10.21%
MORGAN STANLEY ASIA SINGAPORE PTE	22 Aug ‘24	Purchase	35,000	₹5,732.15	10.21%
MORGAN STANLEY ASIA SINGAPORE PTE-ODI	22 Aug ‘24	Purchase	98,000	₹5,732.15	28.58%
RELIANCE NIPPON LIFE INSURANCE COMPANY LIMITED	22 Aug ‘24	Purchase	61,000	₹5,732.15	17.79%
ITI MUTUAL FUND	22 Aug ‘24	Purchase	50,000	₹5,732.15	14.58%

News

13 Nov 2025 12:00 am

Alkem Laboratories Ltd gains for fifth session

13 Nov 2025 12:00 am

Alkem Laboratories consolidated net profit rises 11.10% in the September 2025 quarter

Record Date

Corporate Action

Information

Announcement Day

25 Aug 2025

AGM

29 May 2025

08 Aug 2025

Final Dividend (₹8)

Recommended a final dividend of Rs. 8/- (Rupees Eight only) per equity share of Rs. 2/- each for financial year ended 31 st March, 2025, for the approval of shareholders at the ensuing Annual General Meeting ('AGM') of the Company.

29 May 2025

14 Feb 2025

Interim Dividend (₹37)

Declared an Interim Dividend of Rs. 37/- (Rupees Thirty-Seven only) per equity share on the face value of Rs. 2/- per share for financial year 2024-2025 pursuant to Regulation 43 read with Regulation 30 of SEBI LODR Regulations.

07 Feb 2025

30 Aug 2024

AGM

29 May 2024

10 Aug 2024

Final Dividend (₹5)

The BOD at its meeting held today 29.5.24 has recommended final dividend of Rs. 5 per equity share of Rs. 2 each for FY 31st march 24 for approval of shareholders in the ensuing AGM

29 May 2024

17 Feb 2024

Interim Dividend (₹35)

Interim dividend declared of Rs. 35 per share and pay out on and from 1st March

09 Feb 2024

25 Aug 2023

AGM

19 May 2023

10 Aug 2023

Final Dividend (₹10)

The Board of Directors at its meeting held today i.e. 19th May, 2023, has, inter alia: 1. recommended a final dividend of Rs. 10/- (Rupees Ten only) per equity share of Rs. 2/- each for the financial year ended 31st March, 2023, for the approval of the shareholders of the Company at the ensuing Annual General Meeting. 2. fixed that the 49th Annual General Meeting of the Company shall be held on 25th August, 2023 and the cut-off date for the purpose of the said Annual General Meeting has been fixed as 18th August, 2023. 3. fixed 10th August, 2023 as the record date for the purpose of payment of final dividend. The dividend, if declared by the shareholders, shall be paid on and from 30th August, 2023. The meeting of the Board of Directors of the Company commenced at 11.00 a.m. and concluded at 1.30 p.m. Kindly take the same on record.

19 May 2023

18 Feb 2023

Interim Dividend (₹15)

The Board of Directors of the Company, at its meeting held today, i.e. 10th February, 2023 have inter alia: Interim Dividend of Rs. 15/- (Rupees Fifteen only) per equity share having a face value of Rs. 2/- per share. The meeting of the Board of Directors of the Company commenced at 11.00 a.m. and concluded at 01.10 p.m. Kindly take the same on record.

10 Feb 2023

18 Feb 2023

Special Dividend (₹25)

The Board of Directors of the Company, at its meeting held today, i.e. 10th February, 2023 have inter alia: Special Dividend of Rs. 25/- (Rupees Twenty-Five only) per equity share having a face value of Rs. 2/- per share.

10 Feb 2023

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Debt to Equity(Ratio)	Net Profit Ratio(%)
5,711	68,288	29	5	25	0	17.09%
1,760	4,22,211	37	5	30	0	20.88%
6,475	1,71,898	69	11	59	0	23.41%
3,793	1,28,372	59	15	43	1	16.60%
1,515	1,22,349	22	4	19	0	19.21%
1,244	1,03,789	18	3	14	0	17.54%
2,047	93,506	22	5	17	0	14.56%
928	93,404	19	4	15	0	19.86%
2,224	91,800	53	6	35	0	14.39%
1,240	72,630	21	2	14	0	10.98%

Showing 10 of 124 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in less than 10 mins*

By proceeding, you agree to all T&C *

Top Gainers

Top Losers

Frequently Asked Questions

What is Share Price of Alkem Laboratories Ltd?

The current share price of Alkem Laboratories Ltd (Alkem Lab) is ₹5723.00. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Alkem Laboratories Ltd?

The Price-to-Earnings (P/E) ratio of Alkem Laboratories Ltd is 5723.00. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Alkem Laboratories Ltd?

Alkem Laboratories Ltd has a 52-week high of ₹5868.00 and a 52-week low of ₹4491.65. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Alkem Laboratories Ltd?

Alkem Laboratories Ltd offers a dividend yield of 0.79%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Alkem Laboratories Ltd?

The Earnings Per Share (EPS) of Alkem Laboratories Ltd is ₹196.58. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Alkem Laboratories Ltd?

Alkem Laboratories Ltd has a Return on Equity (ROE) of 19.94%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds.